Navigation Links
Angelica Therapeutics Receives a $244,479 Qualified Therapeutic Discovery Project Grant for Its Anti-Cancer Drug
Date:12/9/2010

EMERYVILLE, Calif., Dec. 9, 2010 /PRNewswire/ -- Angelica Therapeutics, Inc., a privately held drug development company focused on the development and commercialization of therapeutics incorporating novel nonimmunogenic fusion toxins, announced that it has received a $244,479 grant under the IRS Qualified Therapeutic Discovery Project Program. The grant is to advance the development of Angelica's lead drug candidate, Angeloxin, a fusion toxin consisting of deimmunized Diphtheria toxin (DT) fused to Interleukin-2 (IL2).  

The Qualified Therapeutic Discovery Project Program was part of the healthcare reform legislation enacted in March of this year and established a one-time pool of $1 billion for grants to small biotech companies developing novel therapeutics which show potential to, among other things, result in new therapies that either treat areas of unmet medical need, or prevent, detect, or treat chronic or acute diseases and conditions or significantly advance the goal of curing cancer.  

Angelica has collaborated with Antitope, Ltd. (Cambridge, UK) to remove the T cell epitopes from Diphtheria toxin while retaining its cytotoxic potency.  Angeloxin, currently in preclinical development, is the most advanced drug candidate derived from Angelica's technology platform.  It promises to be an advance over Ontak®, currently marketed for the treatment of cutaneous T cell lymphoma and with reports of efficacy in other cancers as well, including peripheral T cell lymphoma and melanoma.

Geoff Davis, CEO of Angelica, said, "We are very pleased to see Angeloxin and the underlying technology platform recognized by this award.  We anticipate that our technology will constitute a significant advance in enabling repeated administration of highly potent and targeted drugs, even to immunocompetent patients, primarily for the treatment of cancer."

About Angelica Therapeutics, Inc. (

SOURCE Angelica Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Talecris Biotherapeutics Enrolls Patients in Clinical Trial Evaluating Two Doses of PROLASTIN®-C
2. Osseon® Therapeutics Names Gary Coughlen, CPA as New Chief Financial Officer
3. Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinsons Disease
4. Orexigen® Therapeutics Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
5. Nile Therapeutics Receives NASDAQ Notice; Will Request Hearing
6. Halozyme Therapeutics Realigns Management
7. Cell Therapeutics Files Appeal on FDA Decision on New Drug Application (NDA) for Pixantrone to Treat Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma
8. The European Medicines Agency Validates and Accepts Cell Therapeutics Marketing Authorization Application for Pixuvri™
9. Nile Therapeutics Reports 2010 Third Quarter Financial Results
10. Ardea Announces Data on MEK Inhibitor BAY 86-9766 (RDEA119) to be Presented at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
11. ImmunGenes Pipeline of Next Generation Cancer Therapeutics Featured in BioWorld Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... April 21, 2015   iRhythm Technologies, Inc. , a ... of cardiac care, announced today that Banner Health, one ... U.S., will now be offering iRhythm,s ZIO ® ... monitoring. "At Banner Health, we are dedicated ... and services," said John Hensing , MD, Banner ...
(Date:4/21/2015)... N.J. , April 21, 2015  Navitas has ... provide a wide range of offerings for life sciences ... providing an integrated platform enabling seamless flow of data ... of the Aviator launch, Navitas worked closely with Oracle ... Hub and Oracle,s CTMS in the Cloud. ...
(Date:4/21/2015)... April 21, 2015  Edico Genome today announced ... with Intel,s Xeon processors to accelerate next generation ... enable completion of primary and secondary NGS analysis ... costs, streamlining data analysis in the cloud and ... big data sets, such as analysis of population-scale ...
Breaking Medicine Technology:Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring 2Banner Health to Offer iRhythm ZIO Service for Continuous Cardiac Monitoring 3Navitas Launches Aviator - Cloud Based Platforms for Oracle Solutions 2Navitas Launches Aviator - Cloud Based Platforms for Oracle Solutions 3Navitas Launches Aviator - Cloud Based Platforms for Oracle Solutions 4Edico Genome Collaborates with Intel to Overcome Big Data Bottleneck in Next-Generation Sequencing 2Edico Genome Collaborates with Intel to Overcome Big Data Bottleneck in Next-Generation Sequencing 3
(Date:4/21/2015)... 2015 The report “Dermatitis ... analysis on the therapeutic development for Dermatitis. ... identifying new targets and MOAs to produce ... TOC is available @ http://www.rnrmarketresearch.com/dermatitis-pipeline-review-h1-2015-market-report.html ... players involved in the therapeutic development for ...
(Date:4/21/2015)... April 21, 2015 QuickMedical, a ... and supplies, now represents Schiller America's ... ECGs, Stress Tests, and Vital Signs Monitors, among ... Switzerland, is a global leader in the development ... are developed in close cooperation with the world's ...
(Date:4/21/2015)... April 21, 2015 Carinsurancehints.com has released ... and explaining their impact on auto insurance prices ... increase auto insurance prices. Clients should review their insurance ... can be bought under several forms. Some of the ... , rivers can compare online rates and find the ...
(Date:4/21/2015)... California (PRWEB) April 21, 2015 On ... Movie Awards” EcoLuxe Lounge at the world famous Avalon ... of sustainable product placement in TV and film, the ... makes appearances at many awards ceremonies and festivals throughout ... top providers of eco-friendly and socially conscious products and ...
(Date:4/21/2015)... April 21, 2015 Edward Avalos, USDA ... “A.G.” Kawamura, former Secretary of the California Department of ... for the 2nd Annual GrowRIVERSIDE Conference: The Future of ... The inclusion of these nationally known experts intensifies an ... planners, farmers and others slated to speak at the ...
Breaking Medicine News(10 mins):Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4Health News:QuickMedical Launches New Product Line: Schiller America 2Health News:QuickMedical Launches New Product Line: Schiller America 3Health News:Heavily Circulated Roads Can increase Auto Insurance Costs 2Health News:Hollywood's Santana Dempsey and Choices Recovery South Bend Examine Victory over Personal Struggles 2Health News:USDA Under Secretary, former CA Agriculture Director to Address 2nd Annual “GrowRIVERSIDE” Conference in June 2Health News:USDA Under Secretary, former CA Agriculture Director to Address 2nd Annual “GrowRIVERSIDE” Conference in June 3
... order to effectively handle the situation in case of an ... to make all necessary preparation.// They are asked to appoint ... European Union would also have to look harder at immediate ... 25 countries. ,He said that their problem is ...
... of psychological stress in the expectant mother might prove ... the Johns Hopkins University and the National Institute of ... in the May/June 2006 edition of the journal Child ... daily stress during pregnancy is associated with more advanced ...
... Space Research Organization (ISRO) announced expansion of its ... hospitals in the country.// Manipal hospital in Banglore, ... Medical Foundation in Maharashtra and Madras Diabetic Research ... ,The telemedicine network, which began in 2001 ...
... its characteristic red color has been discovered to possess ... and heart attacks.// Previous studies have already established cancer ... scientists, the stickiness of platelets - the particles in ... percent when 220 volunteers had a drink containing the ...
... study appearing in the American Journal of Respiratory and Critical ... 11 had a loss in lung capacity equivalent to what ... the terror attacks. ,An average loss of 372 ... the lung's capacity. This loss is at least 10 times ...
... on Monday the major hospitals in Delhi revoked the leave ... were away from duty were recalled. // ,"The ... of Medical Sciences (AIIMS) as resident doctors are on an ... have cancelled all the leave applications and recalled the doctors ...
Cached Medicine News:Health News:Children Benefited By Moderate Maternal Stress? 2Health News:ISRO To Expand Telemedicine Network, 4 Speciality Hospitals To Be Included 2Health News:Delhi Hospitals Cancel Holidays And Recalls Doctors 2Health News:Delhi Hospitals Cancel Holidays And Recalls Doctors 3
... and Fracture Table is a mobile, ... flexible, easy to use, articulated posturing ... orthopedic procedures. Radiolucent abductor bars, wedge-shaped ... exceptional imaging capability. OrthoVision folds into ...
... Mesh Cathode of the OsteoGen™-M mesh ... a scaffolding effect designed to increase ... ends in the management of nonunions. ... particularly appropriate for high-risk patients and ...
Our products, with carefully researched design features, are tailored to making arthroscopic and ligament reconstructive surgery more reproducible, easier, quicker and safer....
... Interference Screw is indicated for graft ... and PCL reconstructions with bone-patellar tendon-bone ... The SmartScrew ACL provides easy and ... for any graft type. The unique ...
Medicine Products: